Utilizing HaloTag Technology to Track the Fate of PCSK9 from Intracellular vs. Extracellular Sources
Open Access
- 1 November 2013
- journal article
- Published by Bentham Science Publishers Ltd. in Current Chemical Genomics
- Vol. 6 (1) , 38-47
Abstract
Utilizing HaloTag Technology to Track the Fate of PCSK9 from Intracellular vs. Extracellular SourcesKeywords
This publication has 21 references indexed in Scilit:
- Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor DegradationJournal of Biological Chemistry, 2009
- PCSK9: a convertase that coordinates LDL catabolismJournal of Lipid Research, 2009
- Molecular basis of PCSK9 functionAtherosclerosis, 2009
- PCSK9 as a therapeutic target of dyslipidemiaExpert Opinion on Therapeutic Targets, 2008
- HaloTag: A Novel Protein Labeling Technology for Cell Imaging and Protein AnalysisACS Chemical Biology, 2008
- The Cellular Trafficking of the Secretory Proprotein Convertase PCSK9 and Its Dependence on the LDLRTraffic, 2007
- Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic miceJournal of Clinical Investigation, 2006
- Dynasore, a Cell-Permeable Inhibitor of DynaminDevelopmental Cell, 2006
- The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular healthThe American Journal of Cardiology, 2004
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003